5,602 Shares in Omega Healthcare Investors, Inc. (NYSE:OHI) Acquired by Garden State Investment Advisory Services LLC

Garden State Investment Advisory Services LLC purchased a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,602 shares of the real estate investment trust’s stock, valued at approximately $228,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its position in Omega Healthcare Investors by 2.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock valued at $4,218,000 after acquiring an additional 3,466 shares in the last quarter. Tidal Investments LLC lifted its position in Omega Healthcare Investors by 2.5% in the 1st quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock valued at $454,000 after acquiring an additional 348 shares in the last quarter. Cetera Investment Advisers lifted its position in Omega Healthcare Investors by 170.6% in the 1st quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust’s stock valued at $3,099,000 after acquiring an additional 61,700 shares in the last quarter. Cetera Advisors LLC bought a new position in Omega Healthcare Investors in the 1st quarter valued at approximately $646,000. Finally, GAMMA Investing LLC lifted its position in Omega Healthcare Investors by 93.4% in the 2nd quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock valued at $84,000 after acquiring an additional 1,181 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 2.0 %

Shares of Omega Healthcare Investors stock opened at $39.81 on Tuesday. The firm has a market cap of $10.75 billion, a price-to-earnings ratio of 29.27, a PEG ratio of 1.26 and a beta of 0.98. The business has a 50-day moving average price of $40.59 and a 200-day moving average price of $37.46. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.73%. Omega Healthcare Investors’s payout ratio is 197.06%.

Analyst Upgrades and Downgrades

OHI has been the topic of several research analyst reports. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Royal Bank of Canada increased their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Wells Fargo & Company reissued an “overweight” rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BMO Capital Markets increased their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Finally, Scotiabank increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of “Hold” and a consensus target price of $40.00.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.